Don't Forget the Public

Ted Agres correctly asserts in his recent article1 that, "...the issue of publicly funded stem cell research will probably not go away." But while he cites support from medical and health research champions in Congress, he fails to cite public opinion on the issue. A recent poll, commissioned by the Coalition for the Advancement of Medical Research--a newly created organization comprised of universities, scientific societies, patients' organizations, and other entities that are devoted to ensu

Written byLawrence Soler
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A recent poll, commissioned by the Coalition for the Advancement of Medical Research--a newly created organization comprised of universities, scientific societies, patients' organizations, and other entities that are devoted to ensuring that federal funding will be available for stem cell research--shows strong public support for such research, with 70 percent of those polled saying they support such research. In addition, 72 percent of Catholics, 63 percent of Fundamentalist Christians, and 56 percent of individuals who are pro life support the research.

We hope that with the strong backing of the public for this research, the Bush administration will make the decision to allow federal funding of this research--research that could save the lives of 100 million Americans who suffer from diseases that could be helped by stem cell research.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies